Am

J Ind Med 38(5):498–506CrossRef Laestadius JG, Ye J, Dimberg L (2008) Can we trust the answers? Reliability and validity of self-reported sick leave due to musculoskeletal symptoms. J Occup Environ Med 50(6):611–613CrossRef Morse TF, Dillon C, Warren N, Levenstein C, Warren A (1998) The economic and social consequences of work-related musculoskeletal disorders: the Connecticut Upper-Extremity selleck chemicals llc Surveillance Project (CUSP). Int J Occup Environ Health 4(4):209–216 Reitsma JB (1999) Registers in cardiovascular epidemiology. Enschede (The Netherlands): PrintPartners Ipskamp, pp 9–40 Riihimäki H, Kurppa K, Karjalainen A, Palo L, Jolanki R, Keskinen H, Mäkinen I, Saalo A, Kauppinen T (2004) Occupational diseases in Finland in 2002. Capmatinib chemical structure Finnish Institute of Occupational Health, Helsinki Sluiter JK, Rest KM, Frings-Dresen MH (2001) Criteria document for evaluating the work-relatedness of upper-extremity musculoskeletal disorders. Scand J Work Environ Health 27(Suppl 1):1–102 Selleckchem Geneticin Sokka T (2005) Assessment of pain in rheumatic diseases. Clin Exp Rheumatol 23(5 Suppl 39):S77–S84 Spreeuwers D, Kuijer PP, Nieuwenhuijsen K, Bakker J, Pal T, Sorgdrager B, van der Laan

G, Stinis HP, Brand T, Gryglicki J (2007) (2007) Signaleringsrapport Beroepsziekten 2007 (Alert Report on Occupational Diseases. Netherlands Center for Occupational Diseases, Amsterdam (in Dutch, with an English summary) Spreeuwers D, de Boer AGEM, Verbeek JHAM, de Wilde NS, Braam I, Willemse Y, Pal TM, van Dijk FJH (2008) Baf-A1 manufacturer Sentinel surveillance of occupational

diseases: a quality improvement project. Am J Ind Med 51(11):834–842CrossRef Streiner DL, Norman GR (2003) Health measurement scales, 3rd edn. Oxford University Press, Oxford, pp 33–34 Van Eerd D, Beaton D, Cole D, Lucas J, Hogg-Johnson S, Bombardier C (2003) Classification systems for upper-limb musculoskeletal disorders in workers: a review of the literature. J Clin Epidemiol 56(10):925–936CrossRef Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483CrossRef”
“Introduction Millions of people worldwide are exposed to arsenic in drinking water (Ravenscroft et al. 2009), an established cause of lung cancer (IARC 2004). Arsenic affects many body tissues, but the human lung seems particularly susceptible (NRC 2001). In fact, lung cancer appears to be the most common cause of death from arsenic in drinking water (Smith et al. 1992; Yuan et al. 2007). Most lung carcinogens—including tobacco smoke, asbestos, and silica—also cause non-malignant respiratory effects. The first evidence that ingested arsenic might follow this pattern came from the limited investigations of children in Antofagasta, Chile (Borgoño et al. 1977; Zaldivar 1980). More recently, studies have linked arsenic in drinking water to lung function, cough, breathlessness, crepitations, chronic bronchitis, and bronchiectasis (De et al. 2004; Guha Mazumder et al.